MMMatthias Mauritz

Matthias Mauritz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Matthias Mauritz has a total of 53 co-authors. Here are the top co-authors by number of shared publications:

  • Eugen Trinka

    Department of Neurology, Neurocritical Care, and Neurorehabilitation, Center for Cognitive Neuroscience, Member of European Reference Network EpiCARE Christian Doppler University Hospital, Paracelsus Medical University Salzburg Austria

    3 shared publications
  • Markus Leitinger

    Department of Neurology Neurocritical Care, and Neurorehabilitation, Christian-Doppler University Hospital, Centre for Cognitive Neuroscience, Member of the European Reference Network EpiCARE, Paracelsus Medical University of Salzburg, Austria

    3 shared publications
  • Andreea Toma

    Department of Neurology, Neurocritical Care, and Neurorehabilitation, Center for Cognitive Neuroscience, Member of European Reference Network EpiCARE Christian Doppler University Hospital, Paracelsus Medical University Salzburg Austria

    2 shared publications
  • Bernardo Crespo Pimentel

    Department of Neurology, Neurocritical Care and Neurorehabilitation, Christian Doppler University Hospital, Centre for Cognitive Neuroscience, Member of the European Reference Network EpiCARE, Paracelsus Medical University of Salzburg, 5020 Salzburg, Austria

    2 shared publications
  • Eugen Trinka

    Department of Neurology, Christian Doppler University Hospital, Paracelsus Medical University and Centre for Cognitive Neuroscience, Salzburg, Austria

    2 shared publications
  • Fabio Rossini

    Department of Neurology, Neurocritical Care, and Neurorehabilitation, Center for Cognitive Neuroscience, Member of European Reference Network EpiCARE Christian Doppler University Hospital, Paracelsus Medical University Salzburg Austria

    2 shared publications

Latest Publications

  • Open Access

    Seminars in epileptology: How to diagnose status epilepticus in adults and children

    by M. Leitinger, P. Bosque‐Varela, G. Kuchukhidze, U. Leitner, J. Höfler, G. Kalss, F. Rossini, G. Pilz, H. Novak, M. Mauritz, et al.

    Status epilepticus (SE) can be regarded as the most severe expression of seizure activity characterized by a low probability of spontaneous cessation and mechanisms leading to metabolic and inflammatory derangements with increased risk of brain damage, alterations of neural networks, and potentially life‐threatening systemic complications. Time‐based criteria are fundamental in diagnosing SE as response to treatment and outcomes worsen with increasing duration in terms of neurological impairment and mortality. Classification of status epilepticus includes four axes: semiology, EEG correlates, etiology, and age. Semiology, especially when evolving from SE with prominent motor phenomena (SE‐PM) to nonconvulsive status epilepticus (NCSE) with impaired consciousness, is associated with drug resistance and poor prognosis. The Salzburg EEG criteria define four subcategories of NCSE. The umbrella term ictal‐interictal continuum (IIC) includes a wide spectrum of EEG changes ranging from almost non‐epileptic situations to conditions that just fail to fulfill the criteria of NCSE. From a pathophysiologic point of view, EEG patterns on the IIC might be generated by both the underlying etiology and the superimposed hypersynchronous epileptic activity. It is impossible to disentangle their relative contributions by visual inspection of the EEG. However, it is essential to identify the contribution of ictal activity in an individual patient as it may be amenable to treatment with antiseizure medication (ASM). The main approach is to perform a diagnostic intravenous ASM trial (diagnostic IV‐ASM trial) during EEG recording and to assess for both EEG and clinical response. Furthermore, CT‐ and MRI‐perfusion studies help to clarify the diagnosis. Early and consequent treatment is necessary to minimize the total time spent in status, also called seizure burden. This educational review focuses on the diagnosis of status epilepticus in children and adults, excluding neonatal status.


  • Open Access

    Epilepsy and employment: A qualitative interview study with heads of human resources and occupational physicians in Austria — A call for legislative optimization according to the WHO Intersectoral Global Action Plan

    by Markus Leitinger, Claudia Klampfer, Leonie Obermeyr, Kateriine Orav, Payam Tabaee Damavandi, Michael Alexa, Aljoscha Thomschewski, Julia Höfler, Fabio Rossini, Giorgi Kuchukhidze, et al.

    Objective: People with epilepsy (PWEs) often face difficulties in obtaining or keeping employment. To determine the views on this topic of the heads of human resources (HHRs) and occupational physicians (OCPs). Method: Twelve HHRs and five OCPs underwent a telephone interview concerning the opportunities and limitations of job applications for PWEs. The interviews were performed in May 2020, in the federal state of Salzburg, Austria, and they were analyzed using the qualitative method of content analysis (Kuckartz). The legal situation was investigated according to Global target 5.2 of the Intersectoral Global Action Plan (IGAP) on epilepsy and other neurological disorders 2022–2031 by WHO. Results: Employers were confident that employees with epilepsy could be managed well in a positive company culture and with first responders in place. The Austrian law predisposes to uncertainty among both employers and employees. In particular, it allows only retrospective juridical clarification of health‐related questions in the job interview. The authors developed a classification system of workplaces, with “D0” (D‐zero) meaning no health or financial danger, for example, office workers and “D1” posing still no health hazard but includes regular work with cash, for example, salespersons. “D2” means potential medical implications for the person with epilepsy or any other person at the workplace, for example, industrial worker. Measures taken to abandon the risk in D2 workplaces, for example, a total sheath for a machine, leads to reclassification as “D2‐0.” With D2, OCPs evaluate the applicant's medical fitness for the job without disclosing medical details to the employer. The “compartment model of medical information in the job application process” guarantees that OCPs are the only persons who learn about the applicant's medical details. Significance: The practical and simple classification of workplaces according to the D‐system, and the concept of making medical information accessible only to OCPs may diminish stigma and discrimination in the working world for PWEs.


  • Open Access

    Case report: Reversible splenial lesion syndrome preceding the onset of multiple sclerosis

    by Matthias Mauritz, Dariia Kliushnikova, Ferdinand Otto, Andrea Harrer, Tobias Moser, Richard Friedrich Radlberger, Waltraud Kleindienst, Eugen Trinka, Peter Wipfler

    Background: The reversible splenial lesion syndrome is frequently associated with systemic and central nervous system infections. Whether an infection associated with the occurrence of the reversible splenial lesion syndrome could play a role in the later development of multiple sclerosis is unknown.Methods: Case Report.Results: A 27-year-old woman developed an infection-related reversible splenial lesion syndrome. Diagnostic findings did not establish a specific type of infection, but revealed evidence for a potential disposition towards autoimmunity. 32 months after the initial presentation, new clinical and radiological manifestations developed that led to a diagnosis of multiple sclerosis.Conclusions: In susceptible individuals, infectious disease processes involving the central nervous system, such as described in this case, might be a factor in the pathogenesis of multiple sclerosis. More research on the prodromal stage of multiple sclerosis is needed to better understand the relationship between infections and autoimmunity.


  • Open Access

    Multiple intracerebral hematomas during SEEG recording and intradural hemorrhage after spinal tap: A case report prompting more research on collagen IV gene mutation and oral nicotine consumption as risk factors

    by Markus Leitinger, Serena Broggi, Mathias Spendel, Gudrun Kalss, Ivan Petrović, Herbert Krainz, Fabio Rossini, Julia Höfler, Andreea Toma, Giorgi Kuchukhidze, et al.

    Intracerebral hemorrhages (ICH) during implantation of stereo‐EEG electrodes are rare. The impact of tobacco‐free nicotine consumption on periprocedural bleeding is uncertain. We present a 20+ year‐old man with drug‐resistant epilepsy who underwent stereo‐EEG with 17 depth electrodes. Within a few days after insertion, the patient developed multiple ICHs in the electrode trajectories and an intradural hemorrhage after a diagnostic spinal tap. We performed the investigation of the clotting system and whole‐exome sequencing (WES). WES identified a heterozygous mutation c.4698G>T, p.(Trp1566Cys) in COL4A2 (NM_001846.4) encoding a collagen type‐IV alpha‐2 chain inherited from his seemingly healthy mother. As COL4A2 mutations had been identified in four adult patients with ICH we postulated that the identified variant presents a potential risk factor. Notably, mutations encoding other collagens have been linked to cerebral hemorrhages (COL4A1) and increased propensity to trigger ICH upon smoking (COL1A2). Our patient consumed at least 24 oral nicotine pouches (containing 11 mg nicotine each) per day. We consider the patient's COL4A2 mutation in combination with his substantial nicotine consumption as likely predisposition to multiple ICHs precipitated by stereo‐EEG. Patients with nicotine consumption and any collagen mutation may have a substantially higher risk for hemorrhagic complications in SEEG and other neurosurgical procedures.Plain Language Summary: A young man with drug‐resistant epilepsy experienced multiple intracerebral hemorrhages after implantation of SEEG electrodes for presurgical evaluation and concomitantly a intradural hemorrhage after a lumbar spinal tap. A collagen IV mutation of unclear significance and heavy use of oral nicotine pouches were the only potential risk factors identified. As collagen mutations were previously described risk factors and smoking in particular worsens the bleeding risk in collagen mutations, further research is warranted to prevent hemorrhages in neurosurgical procedures. Nicotine consumption in any form is a preventable risk factor.


  • Open Access

    MEG in MRI-Negative Patients with Focal Epilepsy

    by Rudolf Kreidenhuber, Kai-Nicolas Poppert, Matthias Mauritz, Hajo M. Hamer, Daniel Delev, Oliver Schnell, Stefan Rampp

    Objectives: To review the evidence on the clinical value of magnetic source imaging (MSI) in patients with refractory focal epilepsy without evidence for an epileptogenic lesion on magnetic resonance imaging (“MRI-negative” or “non-lesional MRI”). Methods: We conducted a systematic literature search on PUBMED, which was extended by researchrabbit.ai using predefined criteria to identify studies that applied MSI in MRI-negative patients with epilepsy. We extracted data on patient characteristics, MSI methods, localization results, surgical outcomes, and correlation with other modalities. Results: We included 23 studies with a total of 512 non-lesional epilepsy patients who underwent MSI. Most studies used equivalent current dipole (ECD) models to estimate the sources of interictal epileptic discharges (IEDs). MEG detected IEDs in 32–100% of patients. MSI results were concordant with other modalities, such as EEG, PET, and SPECT, in 3892% of cases. If MSI concordant surgery was performed, 52–89% of patients achieved seizure freedom. MSI contributed to the decision-making process in 28–75% of cases and altered the surgical plan in 5–33% of cases. Conclusions: MSI is a valuable diagnostic tool for MRI-negative patients with epilepsy, as it can detect and localize IEDs with high accuracy and sensitivity, and provides useful information for surgical planning and predicts outcomes. MSI can also complement and refine the results of other modalities, such as EEG and PET, and optimize the use of invasive recordings. MSI should be considered as part of the presurgical evaluation, especially in patients with non-lesional refractory epilepsy.


  • Open Access

    Diagnosis and Treatment of Poststroke Epilepsy: Where Do We Stand?

    by Matthias Mauritz, Kai-Nicolas Poppert, Eugen Trinka, Sebastian Mutzenbach

    Purpose of Review: Stroke is the most common cause of seizures and epilepsy in older adults. This educational paper aims to give an update on current clinical aspects of diagnosis and treatment of poststroke epilepsy.Recent Findings: Regarding epileptic seizures related to stroke, it is important to distinguish between acute symptomatic seizures and unprovoked seizures as they differ in their risk for seizure recurrence. In fact, after a single unprovoked poststroke seizure, a diagnosis of epilepsy can be made because there is a greater than 60% risk for further seizures. Clinical models that can predict the development of epilepsy after a stroke have been successfully established. However, treatment with anti-seizure medications is advised only after a first unprovoked poststroke seizure, as current treatments are not known to be effective for primary prevention. The management of poststroke epilepsy requires consideration of aspects such as age, drug-drug interactions and secondary vascular prophylaxis, yet evidence for the use of anti-seizure medications specifically in poststroke epilepsy is limited.Summary: This text reviews the epidemiology and risk factors for poststroke epilepsy, explains the role of EEG and neuroimaging in patients with stroke and seizures and provides an overview on the clinical management of stroke-related acute symptomatic seizures and poststroke epilepsy.